Satish Garg, MD
Enriched profileProfessor of Medicine and Pediatrics; Director, Adult Clinic, Barbara Davis Center for Diabetes · University of Colorado Anschutz Medical Campus
Satish Garg is Professor of Medicine and Pediatrics; Director, Adult Clinic, Barbara Davis Center for Diabetes at University of Colorado Anschutz Medical Campus. OpenAlex indexes 514 publications with 27,553 citations (h-index 74); ClinicalTrials.gov lists 7 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Endocrinology, Diabetes & Metabolism profiles in the findmyKOL directory.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Satish K. Garg, MD, is Professor of Medicine and Pediatrics at University of Colorado Anschutz Medical Campus / Barbara Davis Center for Diabetes. The public record shows 514 publications with 27,553 citations (h-index 74), centered on Diabetes Management and Research, Pancreatic function and diabetes, Diabetes Treatment and Management. It also documents an investigator role on 7 registered clinical trials, industry payments reported by 21 companies, 2 NIH-funded awards (1997–2000).
- Top research focus: Diabetes Management and Research
- 7 registered trials on ClinicalTrials.gov
- Open Payments reporting from 21 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 248.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 7 registered studies on ClinicalTrials.gov. The most recent:
- PROMISE Study: An Evaluation of an Implantable Continuous Glucose Sensor up to 180 Days
Sponsor: Senseonics, Inc.
- A Performance Evaluation of the Harmony 1 Sensors in Adults and Pediatrics
Sponsor: Medtronic MiniMed, Inc.
- Adult Accuracy Study of the Enlite 3 Glucose Sensor
Sponsor: Medtronic MiniMed, Inc.
Industry payments
Updated 27 Aug 2026
21 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Novo Nordisk ASProgram year20257 payments$19,468openpaymentsdata.cms.gov ↗
- Dexcom, Inc.Program year20253 payments$10,439openpaymentsdata.cms.gov ↗
- Medtronic, Inc.Program year202513 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
47.2%Insulin Analog27.7%Tresiba Flextouch U-10020%Toujeo Solostar19%Humalog Kwikpen U-10017%Tresiba Flextouch U-20017%Fiasp Flextouch14%Insulin Degludec Pen (U-200)14%Part D<11 patientsGLP-1 receptor agonist14.3%Mounjaro66%Ozempic34%Part D<11 patientsCardiovascular
24.1%Statin11.7%Simvastatin61%Atorvastatin Calcium39%Part D<11 patientsAngiotensin receptor blocker (ARB)7.2%Losartan Potassium100%Part D<11 patientsHormonal (systemic)
14.3%l-Thyroxine14.3%Levothyroxine Sodium100%Part D≥14 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
2 NIH research awards on record, funded 1997–2000 per NIH RePORTER. The latest:
- ORAL ZOPOLRESTAT IN NORMOTENSIVE TYPE I DIABETICS WITH INCIPIENT NEPHROPATHY
University of Colorado Denver
FY2000$32,212M01RR000051 - 28 WEEK MULTICENTER CLINICAL TRIAL COMPARING HOE INSULIN WITH NPH HUMAN INSULIN
University of Colorado Denver
FY2000$19,860M01RR000069 - MULTICENTER TRIAL COMPARING HOE901 INSULIN W/NPH HUMAN INSULIN IN IDDM
University of Colorado Denver
FY2000$19,860M01RR000069
Congress activity
Updated 27 Aug 2026
22 congress contributions (2018–2024) across ADA per OpenAlex. The most recent:
- 1927-LB: Impact of Continuous Glucose Monitoring Use on Hospitalizations in People with Type 2 Diabetes—Real-World Analysis
ADA Scientific Sessions
ADA2024Presenting authorLate-breaking - 355-OR: Glycemic Outcomes with CGM Use in Patients with Type 2 Diabetes—Real-World Analysis
ADA Scientific Sessions
ADA2024Presenting authorOral - 100-LB: Infusion Set Survival and Performance during the Medtronic Extended-Wear Infusion Set (EWIS) Pivotal Trial
ADA Scientific Sessions
ADA2021Co-authorLate-breaking
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Continuous glucose monitoring and metrics for clinical trials: an international consensus statement
The Lancet Diabetes & Endocrinology
2022 - Accuracy and Safety of Dexcom G7 Continuous Glucose Monitoring in Adults with Diabetes
Diabetes Technology & Therapeutics
2022 - Safety and Glycemic Outcomes During the MiniMed™ Advanced Hybrid Closed-Loop System Pivotal Trial in Adolescents and Adults with Type 1 Diabetes
Diabetes Technology & Therapeutics
2021 - Managing New-Onset Type 1 Diabetes During the COVID-19 Pandemic: Challenges and Opportunities
Diabetes Technology & Therapeutics
2020
Most-cited works
by citation count (OpenAlex)- 01
- 02International Consensus on Use of Continuous Glucose Monitoring2,032 citations2017
- 03
- 04
- 05
Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/satish-garg-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - ResearchGate
researchgate.net/profile/Satish-Garg-2
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
Mentions by others
where others cite or feature them- Other
attd2023.kenes.com/celebrating-insulin-centennial/satish-k-garg
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →attd2023.kenes.com ↗ - Other
beyondtype1.org/dka-on-the-rise
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →beyondtype1.org ↗ - Other
cgmeducation.net/faculty_bio.php
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →cgmeducation.net ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medschool.cuanschutz.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medschool.cuanschutz.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →som.cuanschutz.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medschool.cuanschutz.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →som.cuanschutz.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medschool.cuanschutz.edu ↗
Editorial & leadership roles
journal and society appointments- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →attd2023.kenes.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medschool.cuanschutz.edu ↗
- Director
ATDC Keystone Diabetes Conference
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medschool.cuanschutz.edu ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →som.cuanschutz.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →som.cuanschutz.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →som.cuanschutz.edu ↗
Secondary affiliations
appointments beyond the home institution- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →childrenscolorado.org ↗
Media & interviews
press, podcasts and appearances- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →attd2023.kenes.com ↗
- Distinguished Faculty profile
cgmEDUCATION.net (CME/education platform biography feature)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →cgmeducation.net ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Richard Schulick, MD, MBA
University of Colorado Anschutz Medical Campus
John Rumsfeld, MD, PhD
University of Colorado Anschutz Medical Campus
Robert Eckel, MD
University of Colorado Anschutz Medical Campus
Marc Bonaca, MD
University of Colorado Anschutz Medical Campus